ClinicalTrials.Veeva

Menu

Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients (2006/25)

P

Public Assistance-Hospitals of Marseille (AP-HM)

Status

Completed

Conditions

Cytomegalovirus Infection

Treatments

Other: Sampling of blood, phenotypic analysis sub-populations NK by cytometric of stream in multiple markings

Study type

Interventional

Funder types

Other

Identifiers

NCT00699868
2007-A01197-46

Details and patient eligibility

About

This prospective study evaluate the immune status of patients admitted in ICU.CMV remains dormant in the body, but in people with immune deficiency, CMV could reactivate and cause life-threatening pneumonia.

Full description

Candidates will be screened with medical history and blood tests.Then, 2 groups of 20 patients (with or without CMV reactivation) matched for CMV status will be compared for their immune system against CMV.

Enrollment

29 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age more than 18-year-old
  • Informed consent

Exclusion criteria

  • minors,
  • pregnant or lactating women,
  • adults under guardianship,
  • immunosuppression at the entrance to resuscitation,
  • AIDS

Trial design

29 participants in 2 patient groups

1
Experimental group
Description:
Infection to CMV
Treatment:
Other: Sampling of blood, phenotypic analysis sub-populations NK by cytometric of stream in multiple markings
Other: Sampling of blood, phenotypic analysis sub-populations NK by cytometric of stream in multiple markings
2
Other group
Description:
Group "control CMV"
Treatment:
Other: Sampling of blood, phenotypic analysis sub-populations NK by cytometric of stream in multiple markings
Other: Sampling of blood, phenotypic analysis sub-populations NK by cytometric of stream in multiple markings

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems